Myung In Pharmaceutical LTD. (KRX:317450)
South Korea · Delayed Price · Currency is KRW 66,000
+3,600 (5.77%)
At close: Feb 4, 2026
KRX:317450 Market Cap
KRX:317450 has a market cap or net worth of 927.1 billion as of February 5, 2026.
Market Cap
927.10B
Enterprise Value
453.45B
Revenue
283.31B
Ranking
n/a
PE Ratio
9.91
Stock Price
66,000.00
Market Cap Chart
Since October 1, 2025, KRX:317450's market cap has decreased from 1.78T to 927.10B, a decrease of -47.91%. That is a compound annual growth rate of -84.88%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 4, 2026 | 963.60B | -4.21% |
| Dec 30, 2025 | 1.01T | -43.48% |
| Oct 1, 2025 | 1.78T | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| HK inno.N | 1.54T |
| G2GBIO | 1.22T |
| ImmuneOncia Therapeutics | 758.71B |
| Samyang Biopharm | 663.28B |
| HEM Pharma | 635.43B |
| CellBion | 316.94B |
| DAE HWA Pharmaceutical | 273.26B |
| NOVAREX | 245.71B |